Search Medical Condition
Please enter condition
Please choose location from dropdown

Harrow, Germany Clinical Trials

A listing of Harrow, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (121) clinical trials

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 1b: In the dose escalation portion of the study, various cohorts with escalating doses of lenalidomide may be explored, using the 3+3+3 principle for dose determination. Phase 2: This will be conducted as an international, multicenter, open-label study. Eligible subjects will receive ibrutinib, lenalidomide and rituximab.

Phase

1.07 miles

Learn More »

Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities

Bowel cancer is common in the United Kingdom, with around 1 in 16 men and 1 in 20 women developing it at some point in their lives. Most bowel cancers happen when a type of polyp (a growth in the bowel) called an adenoma becomes cancerous. Doctors use a camera ...

Phase N/A

1.56 miles

Learn More »

A Trial of Taurine Supplementation in Parenteral Nutrition 1

Parenteral nutrition associated cholestasis (PNAC) is one of the main causes of death during long-term home parenteral nutrition (HPN). In one study 65% of patients on NPN developed PNAC after a median of 6 months and 41.5% developed HPN associated liver disease after a median of 17 months. It is ...

Phase N/A

1.56 miles

Learn More »

Nutritional Management of Acute and Chronic Enterocutaneous Fistulae

Enterocutaneous fistulae are abnormal connections between bowel and skin through which bowel contents pass. Their management present a considerable medical and surgical challenge. Since the 1970s the mainstray of treatment has been supportive with initiation of a "nil by mouth" regimen and intravenous (parenteral) nutrition with the aim of stabilising ...

Phase N/A

1.56 miles

Learn More »

Experience and Enhancement: Improving Colonoscopic Polyp Detection

Colorectal cancer is the second commonest cause of cancer death. In a majority of cases it is preceeded by a precancerous lesion called an adenoma (commonly known as polyp). Patients with colitis are at specially high risk of colorectal cancer which is estimated to be 18% at 30 years of ...

Phase N/A

1.56 miles

Learn More »

Adenoma Detection Rate:NBI AFI Chromoscopic or Standard Endoscopy

Colorectal cancer is the second commonest cause of cancer death. In majority of cases it is preceeded by a precancerous lesion called an adenoma (commonly known as polyp). Detection and removal of adenomas has been shown to reduce the death rate from colorectal cancer. Despite of meticulous examination "a miss ...

Phase N/A

1.56 miles

Learn More »

Bowel Preparation and Prokinetics in Capsule Endoscopy

Capsule endoscopy is a diagnostic tool for the detection of small bowel disease allowing noninvasive endoscopic examination of the entire small bowel without the need for sedation. Its limited battery life of 8+/-1 hours means it is paramount that the Capsule reaches the caecum, visualizing the whole of the small ...

Phase

1.56 miles

Learn More »

Randomised Trial of NBI for Adenoma Detection

Colorectal cancer is the second commonest cause of cancer death. In a majority of cases it is preceded by a precancerous lesion called an adenoma (polyp). Detection and removal of adenomas at colonoscopy has been shown to reduce the death rate from colorectal cancer. However, despite meticulous examination there is ...

Phase N/A

1.56 miles

Learn More »

NBI With Magnification for Dysplasia Detection in Ulcerative Colitis

Colorectal cancer is the second commonest cause of cancer death. Patients with colitis have a substantially increased risk of death from colorectal cancer which increases with lenght of time the patient has had colitis. This can be as high as a 30% chance of colorectal cancer after 30 years of ...

Phase N/A

1.56 miles

Learn More »

Follow-Up Study of Patients Who Have Undergone Surgery for Stage I Stage II or Stage III Colorectal Cancer

OBJECTIVES: Primary - To assess the effect of augmenting symptomatic follow-up in primary care with two intensive methods of follow-up (monitoring tumor marker in primary care and intensive imaging in hospital) on survival of patients with stage I, II, or III colorectal cancer who have undergone curative resection. Secondary - ...

Phase N/A

1.56 miles

Learn More »